The trajectory of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the loss of exclusivity in key territories has introduced significant read more risk . Investors are now assessing the impact of generic